Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice

Cancer: Principles and Practice of Oncology.

(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,524

Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme

Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,559

Cancer: Principles and Practice of Oncology.

(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-506_5 · Cited by 1,913

Clonal selection and learning in the antibody system

Rajewsky, K. (1996) · Nature · doi:10.1038/381751a0 · Cited by 1,701

Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program

Shaffer, A. L., Lin, K., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Calame, K. L., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00335-7 · Cited by 1,048

Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6

Dent, A. L., Shaffer, A. L., Yu, X., Allman, D., & Staudt, L. M. (1997) · Science · doi:10.1126/science.276.5312.589 · Cited by 950

BCL-6 Represses Genes that Function in Lymphocyte Differentiation, Inflammation, and Cell Cycle Control

Shaffer, A. L., Yu, X., He, Y., Boldrick, J. C., Chan, E. P., & Staudt, L. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00020-0 · Cited by 879

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

Ye, B. H., Cattoretti, G., Shen, Q. “., Zhang, J., Hawe, N., de Waard, R., Leung, C. C., Nouri-Shirazi, M. A., Orazi, A., Chaganti, R. S. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-161 · Cited by 820

Cellular Origin of Human B-Cell Lymphomas

Küppers, R., Klein, U., Hansmann, M., & Rajewsky, K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911113412007 · Cited by 715

The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

Phan, R. T., & Dalla‐Favera, R. (2004) · Nature · doi:10.1038/nature03147 · Cited by 705

The generation of antibody-secreting plasma cells

Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., & Corcoran, L. M. (2015) · Nature reviews. Immunology · doi:10.1038/nri3795 · Cited by 1,565

Germinal centres: role in B-cell physiology and malignancy

Klein, U., & Dalla‐Favera, R. (2007) · Nature reviews. Immunology · doi:10.1038/nri2217 · Cited by 899

EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

Béguelin, W., Popovic, R., Teater, M. R., Jiang, Y., Bunting, K. L., Rosen, M., Shen, H., Yang, S. N., Wang, L., Ezponda, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.011 · Cited by 897

Double-hit B-cell lymphomas

Aukema, S., Siebert, R., Schuuring, E. M. D., Imhoff, G. W. V., Kluin‐Nelemans, H. C., Boerma, E.-J. G., & Kluin, P. M. (2010) · Blood · doi:10.1182/blood-2010-09-297879 · Cited by 677

Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation

Crotty, S., Johnston, R. J., & Schoenberger, S. P. (2010) · Nature Immunology · doi:10.1038/ni.1837 · Cited by 541

Germinal centres and B cell lymphomagenesis

Basso, K., & Dalla-Favera, R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3814 · Cited by 510

Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis

Zhang, J., Dominguez-Sola, D., Hussein, S., Lee, J., Holmes, A. B., Bansal, M., Vlasevska, S., Mo, T., Tang, H., Basso, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3940 · Cited by 493

The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers

Calado, D. P., Sasaki, Y., Godinho, S. A., Pellerin, A., Köchert, K., Sleckman, B. P., de Alborán, I. M., Janz, M., Rodig, S. J., & Rajewsky, K. (2012) · Nature Immunology · doi:10.1038/ni.2418 · Cited by 481

Pathogenesis of Human B Cell Lymphomas

Shaffer, A. L., Young, R. M., & Staudt, L. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075027 · Cited by 457

Roles of BCL6 in normal and transformed germinal center B cells

Basso, K., & Dalla‐Favera, R. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01112.x · Cited by 455

A Signaling Pathway Mediating Downregulation of BCL6 in Germinal Center B Cells Is Blocked by BCL6 Gene Alterations in B Cell Lymphoma

Saito, M., Gao, J., Basso, K., Kitagawa, Y., Smith, P. M., Bhagat, G., Pernis, A. B., Pasqualucci, L., & Dalla‐Favera, R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.011 · Cited by 410

AID is required for germinal center–derived lymphomagenesis

Pasqualucci, L., Bhagat, G., Janković, M., Compagno, M., Smith, P. M., Muramatsu, M., Honjo, T., Morse, H. C., Nussenzweig, M. C., & Dalla‐Favera, R. (2007) · Nature Genetics · doi:10.1038/ng.2007.35 · Cited by 376

Polycomb Group and SCF Ubiquitin Ligases Are Found in a Novel BCOR Complex That Is Recruited to BCL6 Targets

Gearhart, M. D., Corcoran, C. M., Wamstad, J. A., & Bardwell, V. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00630-06 · Cited by 352

BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells

Phan, R. T., Saito, M., Basso, K., Niu, H., & Dalla-Favera, R. (2005) · Nature Immunology · doi:10.1038/ni1245 · Cited by 343

BCL6

Basso, K., & Dalla‐Favera, R. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)05007-8 · Cited by 303

Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis

Sander, S., Calado, D. P., Srinivasan, L., Köchert, K., Zhang, B., Rosołowski, M., Rodig, S. J., Holzmann, K., Stilgenbauer, S., Siebert, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.012 · Cited by 300

Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas

Ding, B. B., Yu, J., Yu, R. Y.-L., Mendez, L., Shaknovich, R., Zhang, Y., Cattoretti, G., & Ye, B. H. (2007) · Blood · doi:10.1182/blood-2007-04-087734 · Cited by 301

FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas

Duan, S., C̆ermák, L., Pagan, J. K., Rossi, M., Martinengo, C., di Celle, P. F., Chapuy, B., Shipp, M. A., Chiarle, R., & Pagano, M. (2011) · Nature · doi:10.1038/nature10688 · Cited by 295

BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell Lymphoma

Mandelbaum, J., Bhagat, G., Tang, H., Mo, T., Brahmachary, M., Shen, Q. “., Chadburn, A., Rajewsky, K., Tarakhovsky, A., Pasqualucci, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.030 · Cited by 290

A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo

Cerchietti, L. C., Ghetu, A. F., Zhu, X., Da Silva, G. F., Zhong, S., Matthews, M., Bunting, K. L., Polo, J. M., Farès, C., Arrowsmith, C. H., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.050 · Cited by 288

Genetics of diffuse large B-cell lymphoma

Pasqualucci, L., & Dalla‐Favera, R. (2018) · Blood · doi:10.1182/blood-2017-11-764332 · Cited by 308

Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR

Ranuncolo, S. M., Polo, J. M., Dierov, J., Singer, M., Kuo, T., Greally, J., Green, R., Carroll, M., & Melnick, A. (2007) · Nature Immunology · doi:10.1038/ni1478 · Cited by 278

Small-molecule-induced polymerization triggers degradation of BCL6

Słabicki, M., Yoon, H., Koeppel, J., Nitsch, L., Roy Burman, S. S., Di Genua, C., Donovan, K. A., Sperling, A. S., Hunkeler, M., Tsai, J. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2925-1 · Cited by 270

Plasma cell development and survival

Oracki, S. A., Walker, J. A., Hibbs, M. L., Corcoran, L. M., & Tarlinton, D. M. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00940.x · Cited by 291

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Winter, J. N. (2006) · Blood · doi:10.1182/blood-2005-10-4222 · Cited by 265

Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis

Cagánová, M., Carrisi, C., Varano, G., Mainoldi, F., Zanardi, F., Germain, P., George, L. A., Alberghini, F., Ferrarini, L., Talukder, A. K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70626 · Cited by 271

EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis

Béguelin, W., Teater, M., Gearhart, M. D., Calvo Fernández, M. T., Goldstein, R. L., Cárdenas, M. G., Hatzi, K., Rosen, M., Shen, H., Corcoran, C. M., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.006 · Cited by 254

POZ for effect – POZ-ZF transcription factors in cancer and development

Kelly, K. F., & Daniel, J. M. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.09.003 · Cited by 256

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

Mestre, C., Rubio-Moscardó, F., Richter, J. Á., Siebert, R., Climent, J., Fresquet, V. J., Beltrán, E., Agirre, X., Marugán, I., Marín, M., et al. (2006) · Blood · doi:10.1182/blood-2006-06-026500 · Cited by 246

Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells

Basso, K., Saito, M., Sumazin, P., Margolin, A. A., Wang, K., Lim, W.-K., Kitagawa, Y., Schneider, C., Alvarez, M. J., Califano, A., et al. (2009) · Blood · doi:10.1182/blood-2009-06-227017 · Cited by 246

The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL

Ci, W., Polo, J. M., Cerchietti, L. C. A., Shaknovich, R., Wang, L., Yang, S. N., Ye, K. Q., Farinha, P., Horsman, D. E., Gascoyne, R. D., et al. (2009) · Blood · doi:10.1182/blood-2008-12-193037 · Cited by 251

Tracking germinal center B cells expressing germ-line immunoglobulin γ1 transcripts by conditional gene targeting

Casola, S. S., Cattoretti, G., Uyttersprot, N., Koralov, S. B., Seagal, J., Hao, Z., Waisman, A., Egert, A., Ghitza, D., & Rajewsky, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602353103 · Cited by 239

Patterns of microRNA expression characterize stages of human B-cell differentiation

Zhang, J., Jima, D. D., Jacobs, C. L., Fischer, R. T., Gottwein, E., Huang, G., Lugar, P., Lagoo, A. S., Rizzieri, D. A., Friedman, D. R., et al. (2009) · Blood · doi:10.1182/blood-2008-09-178186 · Cited by 234

A library of gene expression signatures to illuminate normal and pathological lymphoid biology

Shaffer, A. L., Wright, G. W., Yang, L., Powell, J. I., Ngo, V. N., Lamy, L., Lam, L. T., Davis, R. E., & Staudt, L. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00373.x · Cited by 227

STAT3-Mediated Up-Regulation of BLIMP1 Is Coordinated with BCL6 Down-Regulation to Control Human Plasma Cell Differentiation

Diehl, S. A., Schmidlin, H., Nagasawa, M., van Haren, S. D., Kwakkenbos, M. J., Yasuda, E., Beaumont, T., Scheeren, F. A., & Spits, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4805 · Cited by 233

The genetic network controlling plasma cell differentiation

Nutt, S. L., Taubenheim, N., Hasbold, J., Corcoran, L. M., & Hodgkin, P. D. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.08.010 · Cited by 224

Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances

Zhao, L., Jin, S., Wang, S., Zhang, Z., Wang, X., Chen, Z., Wang, X., Huang, S., Zhang, D., & Wu, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01947-5 · Cited by 261

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

Iqbal, J., Greiner, T. C., Patel, K., Davé, B. J., Smith, L. M., Ji, J. H., Wright, G. W., Sanger, W. G., Pickering, D. L., Jain, S., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404856 · Cited by 216

The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement

Gouill, S. L., Talmant, P., Touzeau, C., Moreau, A., Garand, R., Juge‐Morineau, N., Gaillard, F., Gastinne, T., Milpied, N. J., Moreau, P., et al. (2007) · Haematologica · doi:10.3324/haematol.11305 · Cited by 211

Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach

Abramson, J. S., & Shipp, M. A. (2005) · Blood · doi:10.1182/blood-2005-02-0687 · Cited by 206

Genetic alterations and their clinical implications in DLBCL

Miao, Y., Medeiros, L. J., Li, Y., Li, J., & Young, K. H. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0225-1 · Cited by 208

Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6

Kerres, N., Steurer, S., Schlager, S., Bader, G., Berger, H., Caligiuri, M., Dank, C., Engen, J. R., Ettmayer, P., Fischerauer, B., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.081 · Cited by 207

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

Saito, M., Novak, U., Piovan, E., Basso, K., Sumazin, P., Schneider, C., Crespo, M., Shen, Q. “., Bhagat, G., Califano, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903854106 · Cited by 197

Plasma cell differentiation and survival

Tarlinton, D. M., Radbruch, A., Hiepe, F., & Dörner, T. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.016 · Cited by 198

MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma

Ying, C. Y., Dominguez-Sola, D., Fabi, M., Lorenz, I. C., Hussein, S., Bansal, M., Califano, A., Pasqualucci, L., Basso, K., & Dalla‐Favera, R. (2013) · Nature Immunology · doi:10.1038/ni.2688 · Cited by 203

A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo

Cerchietti, L. C. A., Yang, S. N., Shaknovich, R., Hatzi, K., Polo, J. M., Chadburn, A., Dowdy, S. F., & Melnick, A. M. (2008) · Blood · doi:10.1182/blood-2008-07-168773 · Cited by 184

Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis

Hatzi, K., & Melnick, A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.03.001 · Cited by 183

Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer

Kim, K., Chadalapaka, G., Lee, S.-O., Yamada, D., Sastre‐Garau, X., Defossez, P., Park, Y.-Y., Js, L., & Safe, S. H. (2011) · Oncogene · doi:10.1038/onc.2011.296 · Cited by 186

The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target

Cárdenas, M., Oswald, E. M., Yu, W., Xue, F., MacKerell, A. D., & Melnick, A. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2071 · Cited by 181

The Genetic Landscape of Diffuse Large B-Cell Lymphoma

Pasqualucci, L., & Dalla‐Favera, R. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.01.005 · Cited by 193

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

Cardenas, M. G., Yu, W., Beguelin, W., Teater, M. R., Geng, H., Goldstein, R. L., Oswald, E., Hatzi, K., Yang, S.-N., Cohen, J., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85795 · Cited by 176

TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis

Domínguez, P. M., Ghamlouch, H., Rosikiewicz, W., Kumar, P., Béguelin, W., Fontán, L., Rivas, M. A., Pawlikowska, P., Armand, M., Mouly, E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0657 · Cited by 188

An integrative ENCODE resource for cancer genomics

Zhang, J., Lee, D., Dhiman, V., Jiang, P., Xu, J., McGillivray, P., Yang, H., Liu, J., Meyerson, W., Clarke, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14743-w · Cited by 172

Structure of a BCOR Corepressor Peptide in Complex with the BCL6 BTB Domain Dimer

Ghetu, A. F., Corcoran, C. M., Cerchietti, L., Bardwell, V. J., Melnick, A., & Privé, G. G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.026 · Cited by 168

Translational Regulation of Autoimmune Inflammation and Lymphoma Genesis by Programmed Cell Death 4

Hilliard, A., Hilliard, B., Zheng, S.-J., Sun, H., Miwa, T., Song, W., Göke, R., & Chen, Y. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8095 · Cited by 167

Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements

Sesques, P., & Johnson, N. A. (2016) · Blood · doi:10.1182/blood-2016-02-636316 · Cited by 164

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Lossos, I. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.012 · Cited by 155

Super-enhancer hypermutation alters oncogene expression in B cell lymphoma

Bal, É., Kumar, R., Hadigol, M., Holmes, A. B., Hilton, L. K., Loh, J. W., Dreval, K., Wong, J., Vlasevska, S., Corinaldesi, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04906-8 · Cited by 155

The diverse roles of IRF4 in late germinal center B‐cell differentiation

Silva, N. S. D., Simonetti, G., Heise, N., & Klein, U. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01113.x · Cited by 154

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

McCoull, W., Cheung, T., Anderson, E., Barton, P., Burgess, J., Byth, K., Cao, Q., Castaldi, M. P., Chen, H., Chiarparin, E., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00698 · Cited by 139

Molecular pathways in follicular lymphoma

Bende, R. J., Smit, L. A., & van Noesel, C. J. M. (2006) · Leukemia · doi:10.1038/sj.leu.2404426 · Cited by 141

MicroRNA‐17∼92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways

Jin, H. Y., Oda, H., Lai, M., Skalsky, R. L., Bethel, K. J., Shepherd, J., Kang, S. G., Liu, W., Sabouri-Ghomi, M., Cullen, B. R., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.178 · Cited by 138

From genetics to the clinic: a translational perspective on follicular lymphoma

Huet, S., Sujobert, P., & Salles, G. A. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.127 · Cited by 142

Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas

Polo, J. M., Juszczyński, P., Monti, S., Cerchietti, L. C. A., Ye, K. Q., Greally, J. M., Shipp, M. A., & Melnick, A. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611399104 · Cited by 137

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

Kukreja, A., Hutchinson, A., Dhodapkar, K. M., Mazumder, A., Vesole, D. H., Angitapalli, R., Jagannath, S., & Dhodapkar, M. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052136 · Cited by 134

Stages of Germinal Center Transit Are Defined by B Cell Transcription Factor Coexpression and Relative Abundance

Cattoretti, G., Shaknovich, R., Smith, P. M., Jäck, H., Murty, V. V. V. S., & Alobeid, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6930 · Cited by 134

BCL6 positively regulates AID and germinal center gene expression via repression of miR-155

Basso, K., Schneider, C., Shen, Q. “., Holmes, A. B., Setty, M. N., Leslie, C. S., & Dalla‐Favera, R. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121387 · Cited by 131

Malignant pirates of the immune system

Rui, L., Schmitz, R., Ceribelli, M., & Staudt, L. M. (2011) · Nature Immunology · doi:10.1038/ni.2094 · Cited by 133

A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy

Chen, W., Li, Q., Hudson, W. A., Kumar, A. R., Kirchhof, N., & Kersey, J. H. (2006) · Blood · doi:10.1182/blood-2005-08-3498 · Cited by 130

TBL1XR1 mutations drive extranodal lymphoma by inducing a pro-tumorigenic memory fate

Venturutti, L., Teater, M., Zhai, A., Chadburn, A., Babiker, L., Kim, D., Béguelin, W., Lee, T. C., Kim, Y., Chin, C. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.049 · Cited by 127

The BTB-ZF transcription factors

Siggs, O. M., & Beutler, B. (2012) · Cell Cycle · doi:10.4161/cc.21277 · Cited by 133

STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas

Walker, S. R., Nelson, E. A., & Frank, D. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209775 · Cited by 125

Aberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity

De, S., Shaknovich, R., Riester, M., Elemento, O., Geng, H., Kormáksson, M., Jiang, Y., Woolcock, B. W., Johnson, N. A., Polo, J. M., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003137 · Cited by 122

Targeted Disruption of the S1P 2 Sphingosine 1-Phosphate Receptor Gene Leads to Diffuse Large B-Cell Lymphoma Formation

Cattoretti, G., Mandelbaum, J., Lee, N., Chaves, A. H., Mahler, A. M., Chadburn, A., Dalla‐Favera, R., Pasqualucci, L., & MacLennan, A. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1110 · Cited by 131

PTP1B is a negative regulator of interleukin 4–induced STAT6 signaling

Lu, X., Malumbres, R., Shields, B., Jiang, X., Sarosiek, K. A., Natkunam, Y., Tiganis, T., & Lossos, I. S. (2008) · Blood · doi:10.1182/blood-2008-03-148726 · Cited by 122

BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy

Cerchietti, L. C. A., Hatzi, K., Caldas-Lopes, E., Yang, S. N., Figueroa, M. E., Morin, R. D., Hirst, M., Mendez, L., Shaknovich, R., Cole, P. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42869 · Cited by 119

Cutting Edge: Constitutive B Cell Receptor Signaling Is Critical for Basal Growth of B Lymphoma

Gururajan, M., JENNINGS, C. D., & Bondada, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5715 · Cited by 118

BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells

Ranuncolo, S. M., Polo, J. M., & Melnick, A. (2008) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2008.02.003 · Cited by 116

Regulation of cell differentiation by the DNA damage response

Sherman, M. H., Bassing, C. H., & Teitell, M. A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.01.004 · Cited by 119

Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination

Wesemann, D. R., Magee, J. M., Boboilă, C., Calado, D. P., Gallagher, M. P., Portuguese, A. J., Manis, J. P., Zhou, X. A., Recher, M., Rajewsky, K., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20111155 · Cited by 109

Genetic and epigenetic determinants of diffuse large B-cell lymphoma

Bakhshi, T. J., & Georgel, P. T. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-00389-w · Cited by 109

The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma

Fakhari, F. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26190 · Cited by 107

PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells

Cho, S. H., Goenka, S., Henttinen, T. A., Gudapati, P., Reinikainen, A., Eischen, C. M., Lahesmaa, R., & Boothby, M. R. (2009) · Blood · doi:10.1182/blood-2008-03-144121 · Cited by 114

DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas

Lai, A. Y., Fatemi, M., Dhasarathy, A., Malone, C. C., Sobol, S. E., Geigerman, C., Jaye, D. L., Mav, D., Shah, R., Li, L., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100204 · Cited by 100

Fas ligand–mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas

Afshar‐Sterle, S., Zotos, D., Bernard, N. J., Scherger, A. K., Rödling, L., Alsop, A. E., Walker, J. A., Masson, F., Belz, G. T., Corcoran, L. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3442 · Cited by 105

Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Geng, H., Brennan, S. K., Milne, T. A., Chen, W., Li, Y., Hurtz, C., Kweon, S.-M., Zickl, L., Shojaee, S., Neuberg, D. S., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0208 · Cited by 103

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

Fangazio, M., Ladewig, E., Gomez, K., Garcia‐Ibanez, L., Kumar, R., Teruya‐Feldstein, J., Rossi, D., Filip, I., Pan‐Hammarström, Q., Inghirami, G., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104504118 · Cited by 104

Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells

Phan, R. T., Saito, M., Kitagawa, Y., Means, A. R., & Dalla‐Favera, R. (2007) · Nature Immunology · doi:10.1038/ni1508 · Cited by 97

The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis

Jardin, F., Ruminy, P., Bastard, C., & Tilly, H. (2006) · Pathologie Biologie · doi:10.1016/j.patbio.2006.04.001 · Cited by 94

Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis

Hatzi, K., Geng, H., Doane, A. S., Meydan, C., LaRiviere, R., Cárdenas, M., Duy, C., Shen, H., Calvo-Vidal, M. N., Baslan, T., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0273-1 · Cited by 93

New insights into the regulation of human B-cell differentiation

Schmidlin, H., Diehl, S. A., & Blom, B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.008 · Cited by 100

The B Cell Antigen Receptor and Overexpression of MYC Can Cooperate in the Genesis of B Cell Lymphomas

Refaeli, Y., Young, R. M., Turner, B. C., Duda, J., Field, K. A., & Bishop, J. M. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060152 · Cited by 91

The Impact of DNA Methylation in Hematopoietic Malignancies

Guillamot, M., Cimmino, L., & Aifantis, I. (2016) · Trends in cancer · doi:10.1016/j.trecan.2015.12.006 · Cited by 96

Molecular pathogenesis of diffuse large B-cell lymphoma

Schneider, C., Pasqualucci, L., & Dalla‐Favera, R. (2011) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2011.04.001 · Cited by 90

PTEN C-Terminal Deletion Causes Genomic Instability and Tumor Development

Sun, Z., Huang, C., He, J., Lamb, K. L., Kang, X., Gu, T., Shen, W. H., & Yin, Y. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.030 · Cited by 90

BCOR regulates myeloid cell proliferation and differentiation

Cao, Q., Gearhart, M. D., Gery, S., Shojaee, S., Yang, H. H., Sun, H., Lin, D.-C., Bai, J.-W., Mead, M. D., Zhao, Z., et al. (2016) · Leukemia · doi:10.1038/leu.2016.2 · Cited by 88

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease

Chapuy, B., Cheng, H., Watahiki, A., Ducar, M. D., Tan, Y., Chen, L., Roemer, M. G. M., Ouyang, J., Christie, A. L., Zhang, L., et al. (2016) · Blood · doi:10.1182/blood-2015-09-672352 · Cited by 92

Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma

Green, M. R., Vicente-Dueñas, C., Romero-Camarero, I., Long Liu, C., Dai, B., González-Herrero, I., García-Ramírez, I., Alonso-Escudero, E., Iqbal, J., Chan, W. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4904 · Cited by 88

B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma

Ci, W., Polo, J. M., & Melnick, A. M. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328302c7df · Cited by 86

The BTB-ZF Family of Transcription Factors: Key Regulators of Lineage Commitment and Effector Function Development in the Immune System

Beaulieu, A. M., & Sant’Angelo, D. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004006 · Cited by 87

The BCL6 Oncogene Drives an Epigenomic Program Linking Stem Cells to the Pathogenesis of Human Diffuse Large B Cell Lymphoma in Mice.

Pérez-Caro, M., Cobaleda, C., Piris, M. A., Melnick, A. M., & Snachez-Garcia, I. (2007) · Blood · doi:10.1182/blood.v110.11.3372.3372

Genomic organisation and expression of BCL6 in murine B-cell lymphomas

Qi, C., Hori, M., Coleman, A., Torrey, T. A., Taddesse-Heath, L., Ye, B. H., Chattopadhyay, S. K., Hartley, J. W., & Morse, H. C. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00028-x · Cited by 25

Molekularne mechanizmy działania i patogenetyczna rola deregulacji BCL6 w chłoniaku rozlanym z dużych komórek B — implikacje kliniczne i terapeutyczne

Prusisz, W., Sewastianik, T., & Juszczyński, P. (2012) · Via Medica Journals

Generation of a Murine Model for c-MYC and BCL2 Co-expression B Cell Lymphomas

Cai, Z., Zhang, L., Cao, M., Wang, Y., Wang, F., Bian, W., Zhai, S., & Wang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01007 · Cited by 2

The human BCL6 transgene promotes the development of lymphomas in the mouse

Baron, B. W., Anastasi, J., MONTAG, A. G., Huo, D., Baron, R. M., Karrison, T. G., Thirman, M. J., Subudhi, S. K., Chin, R., Felsher, D. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406138101 · Cited by 73